Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Syndax Pharmaceuticals Announces Appointment of Steve Sabus as Chief Commercial Officer
Syndax Pharmaceuticals, a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, has announced […]
Colleen Flesher Appointed Co-CEO for Movora
Colleen Flesher, currently COO Movora, has been appointed new Co-CEO of veterinary MedTech leader Movora, […]
Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board
Johnson & Johnson has announced that its Board of Directors has elected CEO, Mr. Joaquin […]
Monica Chopra Joins Auxa Health as Co-Founder & CEO
Auxa Health, a leading social care orchestration technology company, announced Monica Chopra, MBA, MPH as its […]
PhRMA Foundation Announces New Members of Board of Directors
The PhRMA Foundation has announced the appointment to its Board of Directors of Aida Habtezion, MD, […]
Bryn Pharma Strengthens Board of Directors with Appointments of Commercial Veterans Sandy Loreaux and William D. Humphries
Bryn Pharma LLC, a privately held pharmaceutical company dedicated to finding a better way for […]
IDEAYA Biosciences Appoints Darrin M. Beaupre, M.D., Ph.D., as Chief Medical Officer
IDEAYA Biosciences, a synthetic lethality-focused precision medicine oncology company committed to the discovery and development […]
Amedisys Names Scott Ginn Acting Chief Operating Officer
Amedisys, a leading provider of home health, hospice, personal care and high-acuity care, names Scott […]
Nanostics Announces New Member of Board of Directors
Nanostics, a precision health diagnostics company, announced today the appointment of Aubrey Rankin to its Board […]
Eden Pharma Announces the Appointment of Mike Parker to Board of Directors
Eden Pharma, the company disrupting the CBD health and wellness industry, announces the appointment of Mike […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more